Stanford Chemicals -Model 040-000-285 -Losartan Potassium, CAS 124750-99-8
Remdesivir (development code GS-5734) is a novel antiviral drug in the class of nucleotide analogs. It is a nucleoside analogue, with effective antiviral activity, with EC50s of 74 nM for SARS-CoV and MERS-CoV in HAE cells, and 30 nM for murine hepatitis virus in delayed brain tumor cells. Remdesivir is highly effective in the control of 2019-nCoV (COVID-19) infection in vitro.
Most popular related searches
COVID 19
active pharmaceutical ingredient
in vitro production
brain cancer cell
hepatitis virus
pharmaceutical ingredient
antiviral drug
brain cancer
cancer cell
COVID-19 product
- Synonyms: GS5437
- Key words: COVID-19, against viruses
- Related products: Hydroxychloroquine sulfate, Losartan Potassium
- Product Name: Remdesivir
- CAS Registry Number: 1809249-37-3
- Molecular Formula: C27H35N6O8P
- Molecular Weight: 602.585 g·mol−1
- Purity: >99.9 %
- Package: 1kg-25kg
- Solubility: DMSO : ≥ 125 mg/mL (207.44 mM)
- Shelf life: 2 years
- Functions: Treatment of COVID-19 infection
Remdesivir is a potent antiviral agent. Remdesivir inhibits murine hepatitis virus (MHV) with an EC50 of 30 nM, and blocks SARS-CoV and MERS-CoV in HAE cells with EC50s of both 74 nM in HAE cells after treatment for 24 h.